{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:30:01Z","timestamp":1791531001999,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01EB009701"],"award-info":[{"award-number":["5R01EB009701"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01AI118182"],"award-info":[{"award-number":["5R01AI118182"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["7R21AR066244"],"award-info":[{"award-number":["7R21AR066244"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.biomaterials.2017.09.031","type":"journal-article","created":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T11:45:33Z","timestamp":1506426333000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers"],"prefix":"10.1016","volume":"149","author":[{"given":"Carolina","family":"Mora-Solano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita S.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca R.","family":"Pompano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel H.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2017.09.031_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrd3003","article-title":"The safety and side effects of monoclonal antibodies","volume":"9","author":"Hansel","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib2","series-title":"Advances in Pharmacology","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/B978-0-12-404717-4.00002-0","author":"Ware","year":"2013"},{"key":"10.1016\/j.biomaterials.2017.09.031_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1359-6101(03)00004-2","article-title":"Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases","volume":"14","author":"Zagury","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib4","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1016\/j.vaccine.2013.06.101","article-title":"Strategies for active TNF-alpha vaccination in rheumatoid arthritis treatment","volume":"31","author":"Jia","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2017.09.031_bib5","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/10878","article-title":"Therapeutic antibodies elicited by immunization against TNF-[alpha]","volume":"17","author":"Dalum","year":"1999","journal-title":"Nat. Biotech."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cellimm.2007.05.005","article-title":"Prepared and screened a modified TNF-alpha molecule as TNF-alpha autovaccine to treat LPS induced endotoxic shock and TNF-alpha induced cachexia in mouse","volume":"246","author":"Wan","year":"2007","journal-title":"Cell Immunol."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib7","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1073\/pnas.0900507106","article-title":"Mechanistic studies of the immunochemical termination of self-tolerance with unnatural amino acids","volume":"106","author":"Gr\u00fcnewald","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1172\/JCI11849","article-title":"Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies","volume":"108","author":"Chackerian","year":"2001","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib9","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.4049\/jimmunol.178.11.7450","article-title":"A\u00a0virus-like particle-based vaccine selectively targeting soluble TNF- protects from arthritis without inducing reactivation of latent tuberculosis","volume":"178","author":"Spohn","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib10","doi-asserted-by":"crossref","first-page":"19442","DOI":"10.1073\/pnas.0604827103","article-title":"TNF\u03b1 kinoid vaccination-induced neutralizing antibodies to TNF\u03b1 protect mice from autologous TNF\u03b1-driven chronic and acute inflammation","volume":"103","author":"Le Buanec","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113465","article-title":"Therapeutic vaccination with TNF-Kinoid in TNF antagonist-resistant rheumatoid arthritis: a phase II randomized, controlled clinical trial","volume":"9","author":"Durez","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2017.09.031_bib12","article-title":"A\u00a0rationally designed TNF-alpha epitope-scaffold immunogen induces sustained antibody response and alleviates collagen-induced arthritis in mice","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2017.09.031_bib13","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/psc.2718","article-title":"Aldehyde modification and alum coadjuvancy enhance anti-TNF-alpha autovaccination and mitigate arthritis in rat","volume":"21","author":"Bavoso","year":"2015","journal-title":"J.\u00a0Pept. Sci."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib14","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.4049\/jimmunol.165.10.5860","article-title":"A\u00a0targeted DNA vaccine augments the natural immune response to self TNF- and suppresses ongoing adjuvant arthritis","volume":"165","author":"Wildbaum","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/ni.1900","article-title":"Control systems and decision making for antibody production","volume":"11","author":"Goodnow","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib16","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2017.09.031_bib17","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.4049\/jimmunol.1003372","article-title":"Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritis","volume":"186","author":"Biton","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib18","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1016\/j.vaccine.2004.01.064","article-title":"Active immunization against murine TNFalpha peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in\u00a0vivo protection","volume":"22","author":"Capini","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2017.09.031_bib19","doi-asserted-by":"crossref","first-page":"8776","DOI":"10.1016\/j.biomaterials.2013.07.063","article-title":"The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation","volume":"34","author":"Chen","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2017.09.031_bib20","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1002\/adhm.201400137","article-title":"Titrating T-cell epitopes within self-assembled vaccines optimizes CD4+ helper T cell and antibody outputs","volume":"3","author":"Pompano","year":"2014","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1073\/pnas.0912124107","article-title":"A\u00a0self-assembling peptide acting as an immune adjuvant","volume":"107","author":"Rudra","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1039\/c0ib00112k","article-title":"Multifactorial optimization of endothelial cell growth using modular synthetic extracellular matrices","volume":"3","author":"Jung","year":"2011","journal-title":"Integr. Biol."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib23","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/j.biomaterials.2009.01.033","article-title":"Co-assembling peptides as defined matrices for endothelial cells","volume":"30","author":"Jung","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2017.09.031_bib24","doi-asserted-by":"crossref","first-page":"9274","DOI":"10.1021\/acsnano.6b03409","article-title":"Switching the immunogenicity of peptide assemblies using surface properties","volume":"10","author":"Wen","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2017.09.031_bib25","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1021\/bm200763y","article-title":"Directed intermixing in multicomponent self-assembling biomaterials","volume":"12","author":"Gasiorowski","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2017.09.031_bib26","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/jps.21152","article-title":"Endotoxin limits in formulations for preclinical research","volume":"97","author":"Malyala","year":"2008","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib27","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0306-3623(95)02141-8","article-title":"Hypothermia as an indicator of the acute effects of lipopolysaccharides: comparison with serum levels of IL1\u03b2, IL6 and TNF\u03b1","volume":"27","author":"Blanqu\u00e9","year":"1996","journal-title":"Gen. Pharmac"},{"key":"10.1016\/j.biomaterials.2017.09.031_bib28","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nmat3998","article-title":"Gradated assembly of multiple proteins into supramolecular nanomaterials","volume":"13","author":"Hudalla","year":"2014","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib29","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/adhm.201200435","article-title":"A\u00a0self-adjuvanting supramolecular vaccine carrying a folded protein antigen","volume":"2","author":"Hudalla","year":"2013","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib30","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1021\/bc034017t","article-title":"Enzymatic modification of self-assembled peptide structures with tissue transglutaminase","volume":"14","author":"Collier","year":"2003","journal-title":"Bioconjug Chem."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-7580-2-2","article-title":"Improved method for predicting linear B-bell epitopes","volume":"2","author":"Larsen","year":"2006","journal-title":"Immunome Res."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1074-7613(94)80017-0","article-title":"Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides","volume":"1","author":"Alexander","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2017.09.031_bib33","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.4049\/jimmunol.178.11.6814","article-title":"Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses","volume":"178","author":"Moutaftsi","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib34","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1126\/science.8248784","article-title":"The influence of antigen organization on B cell responsiveness","volume":"262","author":"Bachmann","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2017.09.031_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cytogfr.2013.12.005","article-title":"Cellular sources of pathogenic and protective TNF and experimental strategies based on utilization of TNF humanized mice","volume":"25","author":"Winsauer","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib36","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nature13323","article-title":"Aryl hydrocarbon receptor control of a disease tolerance defence pathway","volume":"511","author":"Bessede","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2017.09.031_bib37","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1084\/jem.165.3.657","article-title":"Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice","volume":"165","author":"Lehmann","year":"1987","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ajpath.2011.10.001","article-title":"LPS-induced murine systemic inflammation is driven by parenchymal cell activation and exclusively predicted by early MCP-1 plasma levels","volume":"180","author":"Juskewitch","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib39","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1128\/iai.64.3.769-774.1996","article-title":"Lipopolysaccharide-induced lethality and cytokine production in aged mice","volume":"64","author":"Tateda","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nmat4474","article-title":"Supramolecular biomaterials","volume":"15","author":"Webber","year":"2016","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.coi.2015.06.007","article-title":"Supramolecular peptide vaccines: tuning adaptive immunity","volume":"35","author":"Wen","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib42","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1039\/C3TB21549K","article-title":"Engaging adaptive immunity with biomaterials","volume":"2","author":"Mora-Solano","year":"2014","journal-title":"J.\u00a0Mater Chem. B"},{"key":"10.1016\/j.biomaterials.2017.09.031_bib43","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1021\/acschemneuro.5b00345","article-title":"Suppression of cocaine-evoked hyperactivity by self-adjuvanting and multivalent peptide nanofiber vaccines","volume":"7","author":"Rudra","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib44","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1128\/CVI.00714-14","article-title":"Vaccine self-assembling immune matrix is a new delivery platform that enhances immune responses to recombinant HBsAg in mice","volume":"22","author":"Grenfell","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2016.06.019","article-title":"Self-assembling peptide for co-delivery of HIV-1 CD8+ T cells epitope and Toll-like receptor 7\/8 agonists R848 to induce maturation of monocyte derived dendritic cell and augment polyfunctional cytotoxic T lymphocyte (CTL) response","volume":"236","author":"Ding","year":"2016","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2017.09.031_bib46","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1021\/acs.molpharmaceut.6b01003","article-title":"Self-assembling peptide epitopes as novel platform for anticancer vaccination","volume":"14","author":"Rad-Malekshahi","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib47","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1016\/j.biomaterials.2012.05.041","article-title":"Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope","volume":"33","author":"Rudra","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2017.09.031_bib48","doi-asserted-by":"crossref","first-page":"8730","DOI":"10.1021\/ja211725s","article-title":"A\u00a0totally synthetic, self-assembling, adjuvant-free MUC1 glycopeptide vaccine for cancer therapy","volume":"134","author":"Huang","year":"2012","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib49","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1002\/adma.201200209","article-title":"Self-assembled peptide amphiphile micelles containing a cytotoxic t-cell epitope promote a protective immune response in\u00a0vivo","volume":"24","author":"Black","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib50","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1208\/s12248-014-9707-3","article-title":"Peptide amphiphile micelles self-adjuvant group a streptococcal vaccination","volume":"17","author":"Trent","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib51","first-page":"65","article-title":"Self-assembling peptide-based building blocks in medical applications","volume":"110\u2013111","author":"Acar","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib52","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/jbm.a.35767","article-title":"Peptide biomaterials raising adaptive immune responses in wound healing contexts","volume":"104","author":"Vigneswaran","year":"2016","journal-title":"J.\u00a0Biomed. Mater Res. Part A"},{"key":"10.1016\/j.biomaterials.2017.09.031_bib53","doi-asserted-by":"crossref","first-page":"14852","DOI":"10.1073\/pnas.1403271111","article-title":"Antigen affinity and antigen dose exert distinct influences on CD4 T-cell differentiation","volume":"111","author":"Keck","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib54","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1073\/pnas.1119763109","article-title":"Distinct influences of peptide-MHC quality and quantity on in\u00a0vivo T-cell responses","volume":"109","author":"Gottschalk","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2567.2008.03015.x","article-title":"T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity","volume":"126","author":"Stone","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.biomaterials.2017.09.031_bib56","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nri3728","article-title":"Phenotypic models of T cell activation","volume":"14","author":"Lever","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib57","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ni.1704","article-title":"The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding","volume":"10","author":"Fazilleau","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biomaterials.2017.09.031_bib58","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1084\/jem.182.5.1579","article-title":"The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model","volume":"182","author":"Hosken","year":"1995","journal-title":"J.\u00a0Exp. Med."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961217306166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961217306166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:29:01Z","timestamp":1758904141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961217306166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":58,"alternative-id":["S0142961217306166"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2017.09.031","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2017.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}